心血管病学进展2024,Vol.45Issue(1) :35-39.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.010

低氧诱导因子-1在低氧性肺动脉高压中的研究进展

Hypoxia Inducible Factor-1 in Hypoxic Pulmonary Hypertension

金鸿锦 卢义 丁彦春
心血管病学进展2024,Vol.45Issue(1) :35-39.DOI:10.16806/j.cnki.issn.1004-3934.2024.01.010

低氧诱导因子-1在低氧性肺动脉高压中的研究进展

Hypoxia Inducible Factor-1 in Hypoxic Pulmonary Hypertension

金鸿锦 1卢义 1丁彦春1
扫码查看

作者信息

  • 1. 大连医科大学附属第二医院,辽宁大连 116021
  • 折叠

摘要

低氧性肺动脉高压(HPH)是由缺氧引起的肺动脉压力进行性升高的肺血管疾病.低氧诱导因子-1(HIF-1)是维持细胞氧稳态的核心转录因子,可促进细胞糖代谢模式的转变、调节细胞膜表面离子通道活性、调节肺血管收缩及舒张因子活性等,在HPH的发生和发展中具有重要作用.现对HIF-1及其下游信号分子在HPH发生和发展中的作用机制进行综述,有助于为HPH的治疗提供新的理论依据和治疗靶点.

Abstract

Hypoxic pulmonary hypertension(HPH)is a pulmonary vascular disease resulted from progressive increase in pulmonary arterial pressure caused by hypoxia.Hypoxia inducible factor-1(HIF-1)is a core transcription factor which maintains cell oxygen homeostasis,promotes the transformation of glucose metabolism patterns,regulates the activity of the ion channel on the membrane surface and the pulmonary vasoconstriction and relaxation factors,which plays an important role in the occurrence and development of HPH.This review aims to investigate the mechanism of HIF-1 and its downstream signaling molecules in the occurrence and development of HPH,which will provide new theoretical basis and therapeutic target for the treatment of HPH.

关键词

低氧性肺动脉高压/低氧诱导因子-1/低氧性肺血管重塑

Key words

Hypoxic pulmonary hypertension/Hypoxia inducible factor-1/Hypoxic pulmonary vascular remodeling

引用本文复制引用

基金项目

辽宁省自然科学基金(2022-MS-325)

出版年

2024
心血管病学进展
成都市心血管病研究所,成都市第三人民医院

心血管病学进展

CSTPCD
影响因子:0.932
ISSN:1004-3934
参考文献量36
段落导航相关论文